e-learning
resources
Glasgow 2004
Tuesday 07.09.2004
Animal models of allergic airway disease
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Matrix metalloproteinase-8 deletion promotes allergen-induced airway inflammation in mice
M. M. Guerders, M. Balbin, N. Rocks, J. M. Foidart, R. Louis, S. D. Shapiro, C. Lopez-Otin, A. Noel, D. D. Cataldo (Liege, Belgium; Oviedo, Spain; Boston, United States Of America)
Source:
Annual Congress 2004 - Animal models of allergic airway disease
Session:
Animal models of allergic airway disease
Session type:
Oral Presentation
Number:
4021
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. M. Guerders, M. Balbin, N. Rocks, J. M. Foidart, R. Louis, S. D. Shapiro, C. Lopez-Otin, A. Noel, D. D. Cataldo (Liege, Belgium; Oviedo, Spain; Boston, United States Of America). Matrix metalloproteinase-8 deletion promotes allergen-induced airway inflammation in mice. Eur Respir J 2004; 24: Suppl. 48, 4021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
ADAM-8 metalloproteinase drives acute allergen-induced airway inflammation
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Control of allergen-induced inflammation and hyperresponsiveness by the metalloproteinase ADAMTS-12
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
Development of IL-33-induced asthmatic airway inflammation in human IL-3/GM-CSF/IL-5-transgenic NOG mice
Source: International Congress 2017 – "Alarming" immunological patterns in asthma
Year: 2017
Increased expression of Lipocalin2 suppresses allergen-induced airway disease in mice
Source: Annual Congress 2008 - Novel mechanisms and targets of molecular pulmonary pathology
Year: 2008
MMP-9 deficiency reduces airway inflammation and hyperresponsiveness in a mouse model of asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 20s
Year: 2001
Deficiency of MMP-19 promotes allergen-induced eosinophil burden and airway responsiveness in mice
Source: Annual Congress 2007 - Regulation of allergic airway inflammation in animal models of asthma
Year: 2007
Role of macrophage migration inhibitory factor in ovalbumin-induced airway inflammation in rats
Source: Eur Respir J 2006; 27: 726-734
Year: 2006
CCL6 produced by eosinophils drives allergic airway inflammation in mice
Source: International Congress 2019 – Modelling and monitoring of airway diseases
Year: 2019
AQP5 role in ovalbumin-induced airway inflammation and secretion of MUC5AC in mice
Source: Annual Congress 2011 - Animal models of airway inflammation
Year: 2011
Endotoxin interferes with allergy-induced airway inflammation in mice
Source: Eur Respir J 2004; 24: Suppl. 48, 348s
Year: 2004
Effect of neutrophil elastase inhibitor on airway inflammation and airway hyperresponsiveness in a murine model of asthma
Source: Annual Congress 2009 - Animal models of airways inflammation
Year: 2009
Increase in laminin expression in allergic airway remodelling and decrease by dexamethasone
Source: Eur Respir J 2004; 24: 107-115
Year: 2004
Matrix metalloproteinase inhibitor inhibits lipopolysaccharide-induced goblet-cell hyperplasia in rat airway
Source: Eur Respir J 2002; 20: Suppl. 38, 572s
Year: 2002
Role of cytokines and chemokines in bronchial hyperresponsiveness and airway inflammation and remodelling
Source: Annual Congress 2007 - PG1 - Asthma: from bench to bedside
Year: 2007
Matrix metalloproteinase inhibitor regulates inflammatory cells migration through reducing ICAM-1 and VCAM-1 expression in a murine model of toluene diisocyanate-induced asthma
Source: Eur Respir J 2003; 22: Suppl. 45, 483s
Year: 2003
Matrix metalloproteinase (MMP)-2 production by fibroblasts and mast cells: the role in pulmonary fibrosis
Source: Eur Respir J 2004; 24: Suppl. 48, 455s
Year: 2004
Effects of OVA-induced allergic airway inflammation and remodeling in mice in three distinct asthma models
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
MMP-9 and airway neutrophilia
Source: Annual Congress 2004 - Inflammation and remodelling in human lungs
Year: 2004
Estrogen protects against airway inflammation via upregulation of SLPI and downregulation of IL-33
Source: Annual Congress 2012 - Asthma: mechanisms of airway inflammation
Year: 2012
Smooth-muscle-derived WNT-5A drives allergen-induced remodelling and Th2 type inflammation
Source: International Congress 2018 – Preclinical pharmacology: novel targets in airway inflammation, narrowing and neural control
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept